Lentivirus-mediated gene therapy for Fabry disease.
Nature Communications
Khan, Aneal A; Barber, Dwayne L DL; Huang, Ju J; Rupar, C Anthony CA; Rip, Jack W JW; Auray-Blais, Christiane C; Boutin, Michel M; O'Hoski, Pamela P; Gargulak, Kristy K; McKillop, William M WM; Fraser, Graeme G; Wasim, Syed S; LeMoine, Kaye K; Jelinski, Shelly S; Chaudhry, Ahsan A; Prokopishyn, Nicole N; Morel, Chantal F CF; Couban, Stephen S; Duggan, Peter R PR; Fowler, Daniel H DH; Keating, Armand A; West, Michael L ML; Foley, Ronan R; Medin, Jeffrey A JA
Variable clinical features of patients with Fabry disease and outcome of enzyme replacement therapy.
Molecular Genetics And Metabolism Reports
Dutra-Clarke, Marina M; Tapia, Daisy D; Curtin, Emily E; Rünger, Dennis D; Lee, Grace K GK; Lakatos, Anita A; Alandy-Dy, Zyza Z; Freedkin, Linda L; Hall, Kathy K; Ercelen, Nesrin N; Alandy-Dy, Jousef J; Knight, Margaret M; Pahl, Madeleine M; Lombardo, Dawn D; Kimonis, Virginia V
Assessment of Gene Variant Amenability for Pharmacological Chaperone Therapy with 1-Deoxygalactonojirimycin in Fabry Disease.
International Journal Of Molecular Sciences
Lukas, Jan J; Cimmaruta, Chiara C; Liguori, Ludovica L; Pantoom, Supansa S; Iwanov, Katharina K; Petters, Janine J; Hund, Christina C; Bunschkowski, Maik M; Hermann, Andreas A; Cubellis, Maria Vittoria MV; Rolfs, Arndt A
Elevated Inflammatory Plasma Biomarkers in Patients With Fabry Disease: A Critical Link to Heart Failure With Preserved Ejection Fraction.
Journal Of The American Heart Association
Yogasundaram, Haran H; Nikhanj, Anish A; Putko, Brendan N BN; Boutin, Michel M; Jain-Ghai, Shailly S; Khan, Aneal A; Auray-Blais, Christiane C; West, Michael L ML; Oudit, Gavin Y GY
Mosaicism of podocyte involvement is related to podocyte injury in females with Fabry disease.
Plos One
Mauer, Michael M; Glynn, Emily E; Svarstad, Einar E; Tøndel, Camilla C; Gubler, Marie-Claire MC; West, Michael M; Sokolovskiy, Alexey A; Whitley, Chester C; Najafian, Behzad B
A pharmacogenetic approach to identify mutant forms of α-galactosidase A that respond to a pharmacological chaperone for Fabry disease.
Human Mutation
Wu, Xiaoyang X; Katz, Evan E; Della Valle, Maria Cecilia MC; Mascioli, Kirsten K; Flanagan, John J JJ; Castelli, Jeffrey P JP; Schiffmann, Raphael R; Boudes, Pol P; Lockhart, David J DJ; Valenzano, Kenneth J KJ; Benjamin, Elfrida R ER
Decreased glucocerebrosidase activity in Gaucher disease parallels quantitative enzyme loss due to abnormal interaction with TCP1 and c-Cbl.
Proceedings Of The National Academy Of Sciences Of The United States Of America
Lu, Jie J; Chiang, Jeffrey J; Iyer, Rajiv R RR; Thompson, Eli E; Kaneski, Christine R CR; Xu, David S DS; Yang, Chunzhang C; Chen, Masako M; Hodes, Richard J RJ; Lonser, Russell R RR; Brady, Roscoe O RO; Zhuang, Zhengping Z
Screening for pharmacological chaperones in Fabry disease.
Biochemical And Biophysical Research Communications
Shin, Sang-Hoon SH; Murray, Gary J GJ; Kluepfel-Stahl, Stefanie S; Cooney, Adele M AM; Quirk, Jane M JM; Schiffmann, Raphael R; Brady, Roscoe O RO; Kaneski, Christine R CR